MedTrace Logo

The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease

NCT01765439 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2026-04-23

No results posted yet for this study

Summary

The aim of the study is to determine, whether administration of VSL#3 (Original De Simone formulation) probiotic preparation can alter the bile acid metabolism in patients with inflammatory bowel disease.

Conditions

Interventions

DIETARY_SUPPLEMENT

VSL#3 (Original De Simone formulation)

Study subjects will receive two sachets of VSL#3 probiotic (ie 2x900 billions of live bacteria) per day (one in the morning, one in the evening). The intervention period will be 6 weeks (plus or minus 5 days).

Sponsors & Collaborators

  • Iscare i.v.f., Czech Republic

    collaborator UNKNOWN

  • CD Investments srl

    collaborator UNKNOWN

  • University Of Perugia

    collaborator OTHER

  • University of Roma La Sapienza

    collaborator OTHER

  • Charles University, Czech Republic

    lead OTHER

Principal Investigators

  • Martin Lenicek, MD, Ph.D. · Charles University, Czech Republic

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2027-08-31
Completion
2027-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01765439 on ClinicalTrials.gov